期刊
NEUROLOGY
卷 62, 期 11, 页码 1972-1976出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.WNL.0000129504.60409.88
关键词
-
资金
- NIA NIH HHS [1K08AG20856-01, AG07232, AG07702, 2P30AG15294-06] Funding Source: Medline
Objective: To explore the association between high homocysteine levels and risk of Alzheimer disease ( AD) in the Washington Heights-Inwood Columbia Aging Project (WHICAP). Methods: The authors obtained fasting plasma samples in 909 elderly subjects chosen at random from a cohort of Medicare recipients; there was longitudinal data in 679 subjects without dementia at baseline who were followed for 3,206 person-years. Prevalent and incident dementia and its subtypes were diagnosed using standard methods. Results: There were 128 persons with prevalent AD and 109 with incident AD in 3,206 person-years of follow-up. The adjusted OR of prevalent AD for the highest quartile of homocysteine compared to the lowest was 1.3 (95% CI = 0.7, 2.3; p for trend = 0.25). In longitudinal analyses, the authors found that the adjusted hazard ratio of AD for the highest quartile of homocysteine was 1.4 (95% CI = 0.8, 2.4; p for trend = 0.31). The authors also found that high homocysteine levels were not related to a decline in memory scores over time. Age was a significant confounder in all the analyses. The study had 80% power to detect a hazard ratio of 1.3 in the longitudinal analyses. Conclusion: High homocysteine levels were not associated with AD and were not related to a decrease in memory scores over time.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据